Johns Hopkins ABX Guide
Sofosbuvir + velpatasvir
INDICATIONS
FDA
FDA
Treatment of adult patients with chronic HCV genotype 1, 2, 3, 4, 5 or 6 without cirrhosis or with compensated cirrhosis or with decompensated cirrhosis in combination with ribavirin
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: July 27, 2020
Citation
Smith, Janessa M. "Sofosbuvir + Velpatasvir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2020. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540699/all/Sofosbuvir_+_velpatasvir.
Smith JM. Sofosbuvir + velpatasvir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540699/all/Sofosbuvir_+_velpatasvir. Accessed September 26, 2023.
Smith, J. M. (2020). Sofosbuvir + velpatasvir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540699/all/Sofosbuvir_+_velpatasvir
Smith JM. Sofosbuvir + Velpatasvir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2020. [cited 2023 September 26]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540699/all/Sofosbuvir_+_velpatasvir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sofosbuvir + velpatasvir
ID - 540699
A1 - Smith,Janessa,PharmD, BCPS
Y1 - 2020/07/27/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540699/all/Sofosbuvir_+_velpatasvir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
